Heartbeam Inc (BEAT) Stock Analysis

Heartbeam Inc (BEAT) is a publicly traded company in the HEALTHCARE sector. It trades at $0.88, carries a market capitalization of $48.90M. This page summarizes the public market data, fundamentals, and frequently asked questions for BEAT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.88
• Market Cap: $48.90M
• EPS: $-0.56
• 52-Week High: $4.00
• 52-Week Low: $0.54

Market Sentiment

Heartbeam Inc currently has a Bullish sentiment score of 0.37.

About Heartbeam Inc

Heartbeam Inc. (BEAT) is a pioneering remote medical technology company headquartered in Malvern, Pennsylvania, dedicated to revolutionizing cardiovascular care through its advanced remote heart monitoring solutions. The firm specializes in proprietary cardiac diagnostics technology, addressing urgent healthcare challenges by providing real-time monitoring capabilities. With a strong focus on improving patient outcomes, Heartbeam is positioned as a valuable partner for healthcare providers an...

GNG Research Analysis

GNG Research scores Heartbeam Inc (BEAT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BEAT.

Frequently Asked Questions

Does BEAT pay dividends?

Heartbeam Inc (BEAT) does not currently pay a regular dividend.

What is BEAT's market cap?

Heartbeam Inc (BEAT) has a market capitalization of $48.90M with a current stock price of $0.88.